Related Experiment Videos
Correlation between the clinical classification of bronchial asthma severity and the methacholine test in children
1Servicio de Pediatría, Universidad, Austral de Chile.
Insights
The Methacholine Bronchial Challenge Test effectively diagnoses bronchial hyperreactivity in children. Its accuracy varies with asthma severity, showing high sensitivity in mild cases but decreasing in severe asthma, potentially due to prior corticoid use.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Diagnostics
Background:
- Bronchial asthma is a common chronic respiratory disease in children.
- Accurate clinical classification is crucial for effective asthma management.
- Bronchial hyperreactivity is a key feature of asthma.
Purpose of the Study:
- To validate the Methacholine Bronchial Challenge Test (MBCT) across different asthma severity levels.
- To compare MBCT results with established clinical asthma classifications in pediatric patients.
- To assess the diagnostic utility of MBCT for bronchial hyperreactivity in children.
Main Methods:
- Fifty-four children over 6 years old with asthma were clinically classified.
- Patients underwent the Methacholine Bronchial Challenge Test.
- Sensitivity and specificity of MBCT were calculated for mild, moderate, and severe asthma groups.
Main Results:
- MBCT demonstrated high sensitivity (100%) and specificity (92.3%) in mildly asthmatic children.
- In moderately asthmatic children, sensitivity was 84.5% with maintained specificity (92.3%).
- Severely asthmatic children showed decreased sensitivity (53.5%) but increased specificity (97.2%), possibly due to prior corticoid treatment.
Conclusions:
- The Methacholine Bronchial Challenge Test is valuable for diagnosing bronchial hyperreactivity, especially in ambiguous cases.
- MBCT aids in the clinical classification of pediatric asthma patients when combined with clinical findings.
- The test's performance varies by asthma severity, necessitating careful interpretation in relation to patient history, including medication use.
Abstract:
The purpose of this study was to validate the Methacholine Bronchial Challenge Test in its different degrees and to compare them with the different clinical classifications of bronchial asthma. Fifty-four child asthmatic patients over 6 years of age from the Respiratory Outpatient Clinic at La Union Hospital (Chile) were submitted to the clinical classification of bronchial asthma and later to the Methacholine Bronchial Challenge Test, which classified the children as mildly, moderately or severely hyperreactive to the test. In mildly asthmatic children, the Methacholine Test showed both a high sensitivity (100%) and specificity (92.3%). In moderately asthmatic children, the sensitivity decreased to 84.5%, whilst the specificity was maintained (92.3%). In severely asthmatic children, however, the sensitivity decreased to 53.5%, whilst the specificity increased 97.2%. The latter could be explained as a consequence of the previous exposure of this group of children to either inhaled or oral corticoids. According to our experience, the Methacholine Test is not only useful for the diagnosis of bronchial hyperreactivity in dubious cases, but also for contributing together with the clinical findings to the adequate classification of these patients.